Cocrystal Pharma, Inc. (COCP)

1.18 +0.04 (+3.51%) USD  |  NASDAQ  |  Sep 18, 16:00
More

Cocrystal Pharma Revenue Estimates for Next Fiscal Year

Revenue Estimates for Next Fiscal Year Chart

View Revenue Estimates for Next Fiscal Year for COCP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Next Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
August 20, 2026 --
June 01, 2026 --
April 07, 2026 --
February 23, 2026 --
November 18, 2025 --
October 23, 2025 --
September 17, 2025 --
August 19, 2025 --
August 15, 2025 --
June 20, 2025 --
May 27, 2025 --
April 01, 2025 --
January 08, 2025 --
August 22, 2024 --
August 19, 2024 --
July 20, 2024 --
Date Value
May 16, 2024 --
April 23, 2024 --
April 04, 2024 --
February 20, 2024 --
November 14, 2023 --
November 03, 2023 --
November 01, 2023 --
October 04, 2023 --
October 02, 2023 --
August 16, 2023 --
August 15, 2023 --
August 11, 2023 --
May 24, 2023 --
May 17, 2023 --
May 15, 2023 --
April 05, 2023 --

Revenue Estimates for Next Fiscal Year Range, Past 5 Years

View Revenue Estimates for Next Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Fiscal Year Benchmarks

View Revenue Estimates for Next Fiscal Year Benchmarks
Start Trial
CNBX Pharmaceuticals, Inc. --
GB Sciences, Inc. --
Arvinas, Inc. Upgrade
Fulcrum Therapeutics, Inc. Upgrade
Definium Therapeutics, Inc. Upgrade

Revenue Estimates for Next Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade